Common Stock |
6 Months Ended | ||||||
|---|---|---|---|---|---|---|---|
Jun. 30, 2025 | |||||||
| Equity [Abstract] | |||||||
| Common Stock |
Common Stock 2025. During the three months ended June 30, 2025, the Company issued approximately 1.3 million shares of common stock primarily in connection with vesting of stock-based awards. During the six months ended June 30, 2025, the Company issued approximately 2.1 million shares of common stock primarily in connection with vesting of stock-based awards. 2024. During the three months ended June 30, 2024, the Company issued approximately 0.6 million shares of common stock primarily in connection with exercises and vesting of stock-based awards. During the six months ended June 30, 2024, the Company issued approximately 3.1 million shares of common stock primarily in connection with exercises and vesting of stock-based awards. Additionally, during the six months ended June 30, 2024, the Company issued approximately 2.0 million shares of common stock to settle liabilities related to the exchange of common stock for reduced physician partner compensation percentage in certain ACO REACH entities.
|
||||||